NUCEIVA

evolus incorporated🇨🇦 Health Canada

Approval Id: 340b8f2a3fbefa6c
Drug Approval Canada Name: NUCEIVA
Product Name: NUCEIVA
Status: Marketed
Status Date: 2019-10-16
Original Market Date: 2019-10-16
Din: 02480158
Drug Class: Human
Dosage Form: Powder For Solution
Route Of Administration: Intramuscular
Schedule: Schedule D , Prescription
Ahfs: 12:20.20.24
Atc Original: M03AX01 BOTULINUM TOXIN
Atc Name: m 03 ax 01
Aig Number: 0160590001
Company Name: evolus incorporated
Company Address: 1200, 520 Newport Center Drive, Newport Beach, California, United States, 92660

PRABOTULINUMTOXINA

100 UNIT / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

340b8f2a3fbefa6c

Type

Standard